Fundz

Exscientia Appoints John P. Overington as Chief Technology Officer and Marie-Louise Fjällskog, M.D., Ph.D., as Interim Chief Medical Officer

PRIVATEJun 06, 2024

Position

Clinical Development Lead

Company

Exscientia

Marie-Louise Fjällskog, M.D., Ph.D.
OxfordBiotechnologySoftwareData And AnalyticsHealth CareScience And EngineeringArtificial Intelligence

Description

Exscientia plc has appointed John P. Overington, Ph.D., as Chief Technology Officer to lead the company’s technology solutions and Marie-Louise Fjällskog, M.D., Ph.D., as the company’s interim Chief Medical Officer and Clinical Development Lead to strengthen the clinical development strategy.

Who to call at Exscientia, and when

A new leader at Exscientia brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Exscientia raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Exscientia, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Exscientia

Location

Oxford, Mississippi, United States

About

Exscientia is an AI-driven pharmatech company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner. Exscientia developed the first-ever functional precision oncology platform to successfully guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting. Our pipeline demonstrates our ability to rapidly translate scientific concepts into precision-designed therapeutic candidates, with more than 25 projects advancing, including the first three AI-designed drug candidates to enter Phase 1 clinical trials.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Exscientia changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Exscientia's next move

Learn about Strategic plan

Exscientia changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.